Ken Griffin Mckesson Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$479.06 - $630.38 $14.3 Million - $18.8 Million	29,800 Added 19.29%	184,300 $91.1 Million
Q2 2024 Aug 14, 2024	SELL	$518.81 - $607.81 $10.2 Million - $12 Million	-19,700 Reduced 11.31%	154,500 $90.2 Million
Q1 2024 May 15, 2024	SELL	$473.42 - $539.26 $8 Million - $9.11 Million	-16,900 Reduced 8.84%	174,200 $93.5 Million
Q4 2023 Feb 14, 2024	BUY	$437.42 - $470.64 $11.2 Million - $12 Million	25,500 Added 15.4%	191,100 $88.5 Million
Q3 2023 Nov 14, 2023	BUY	$402.4 - $446.42 $2.49 Million - $2.77 Million	6,200 Added 3.89%	165,600 $72 Million
Q2 2023 Aug 14, 2023	SELL	$354.01 - $427.31 $7.4 Million - $8.93 Million	-20,900 Reduced 11.59%	159,400 $68.1 Million
Q1 2023 May 15, 2023	SELL	$335.35 - $386.06 $61.9 Million - $71.2 Million	-184,500 Reduced 50.58%	180,300 $64.2 Million
Q4 2022 Feb 14, 2023	SELL	$346.68 - $397.58 $91.2 Million - $105 Million	-263,000 Reduced 41.89%	364,800 $137 Million
Q3 2022 Nov 14, 2022	BUY	$321.25 - $373.84 $112 Million - $131 Million	349,900 Added 125.91%	627,800 $213 Million

1,690

108M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $83.2B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.